Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Osteoporosis and Sarcopenia
>
2019
>
5
>
2
Volume:
5
Issue:
2
1. How different is the once-weekly teriparatide from the daily one or the same?
Page:27—28
2. Diabetes and bone
Page:29—37
3. The incidence of hip fracture and mortality rate after hip fracture in Korea: A nationwide population-based cohort study
Page:38—43
4. Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk
Page:44—50
5. Impact of patient background factors on the treatment efficacy of once-weekly teriparatide
Page:51—56
6. Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
Page:57—61